Business Context and Reporting Period
Zimmer Biomet Holdings, Inc. (ZBH) filed a Form 8-K on June 27, 2025, reporting the entry into new material definitive credit agreements and the termination of prior facilities. The company is incorporated in Delaware and maintains its principal executive offices in Warsaw, Indiana.
Key Financial Metrics and Debt Structure
The filing details the restructuring of the company's revolving credit facilities rather than reporting operational financial results such as revenue or profit.
- New Five-Year Revolving Facility: $1.5 billion unsecured facility maturing June 27, 2030, with two optional one-year extensions.
- New 364-Day Revolving Facility: $1.0 billion unsecured facility maturing June 26, 2026.
- Incremental Capacity: An uncommitted feature allows for an additional $500 million increase to the Five-Year Facility.
- Initial Borrowing: $50.0 million borrowed under the new Five-Year Credit Agreement on June 27, 2025.
- Interest Rates: Floating rates based on adjusted Term SOFR or an alternate base rate plus a margin tied to the company's credit rating.
Material Changes Versus Prior Period
The company terminated its previous credit agreements dated June 28, 2024, effective June 27, 2025.
- Terminated Facilities: The 2024 Five-Year Credit Agreement and the 2024 364-Day Credit Agreement were terminated.
- Outstanding Balance Transition: Approximately $50.7 million was outstanding under the 2024 Five-Year Credit Agreement. Of this, $50.0 million was refinanced into the new Five-Year Credit Agreement, and approximately $0.7 million was repaid with cash on hand.
- Letters of Credit: All existing letters of credit under the 2024 agreement were transitioned to the new Five-Year Credit Agreement.
- 364-Day Facility Status: There was no principal balance outstanding under the terminated 2024 364-Day Credit Agreement.
Covenants, Risks, and Management Commentary
The new agreements contain customary affirmative and negative covenants, including limitations on consolidations, mergers, and asset sales.
- Financial Covenants: The company must maintain a consolidated indebtedness to consolidated EBITDA ratio of no greater than 4.5 to 1.0 over any four consecutive fiscal quarters.
- Covenant Flexibility: The ratio may increase to 5.0 to 1.0 in connection with a qualified material acquisition or under certain other restrictions.
- Related Party Transactions: Lenders and their affiliates may provide investment banking, commercial banking, and other financial services to the company for compensation.
Investor Verification Checklist
- Verify the current consolidated indebtedness to EBITDA ratio to ensure compliance with the 4.5:1.0 covenant.
- Review the full text of the Five-Year and 364-Day Credit Agreements (Exhibits 10.1 and 10.2) for specific definitions of "qualified material acquisition" and other covenant exceptions.
- Monitor the company's credit rating, as interest margins and facility fees are directly tied to the senior unsecured long-term debt rating.
- Confirm the status of the $0.7 million cash repayment and its impact on immediate liquidity.